Work

GLP-1 Receptor Agonist Semaglutide and Risk of Incident Urinary Stone Disease

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of the American Society of Nephrology

DOI: 10.1681/asn.20253gqh8bva

Authors: Calyani Ganesan, Sun H. Kim, Timothy Chan Chang, Simon Conti, John Leppert, Alan C. Pao

Institutions: Stanford Medicine, Stanford University, VA Palo Alto Health Care System

Language: English

Topic: Kidney Stones and Urolithiasis Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415475995

FWCI: 0.608

Cites:

Cited by: 1

Related to: